Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-HT2 receptor antagonists(Serotonin 2 (5-HT2) receptor antagonists), ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H31FN4O3 |
InChIKeyNJODDWBWSIFQMT-UHFFFAOYSA-N |
CAS Registry136975-64-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 1 | JP | - | |
Hypertension | Phase 1 | - | - | |
Myocardial Ischemia | Phase 1 | - | - | |
Myocardial Ischemia | Phase 1 | JP | - | |
Thrombosis | Phase 1 | JP | - | |
Thrombosis | Phase 1 | - | - |